The world of finance is nothing if not risky. However, when a risk culture is instilled in your organization, you can set the stage for long-term sustainable growth. When risks are anticipated and ...

At the dawn of the 21st century, venous thromboembolism (VTE) treatment remained in the dark ages. Backed by an MD and a legacy of paternalistic practice, we convinced patients to do what now seems ...

MammaPrint effectively predicts chemotherapy benefit and distant recurrence-free interval in HR+HER2- early breast cancer. High-risk patients benefit significantly from chemotherapy, while low-risk ...

August 16, 2011 (Silver Spring, Maryland) — As part of its ongoing effort to be more transparent about its decision-making process, the FDA has drafted a guidance document to clarify, for both its own ...

Many U.S. corporate pension plans have seen funding levels materially improve in recent years. Strong equity markets and higher rates have put many plans near or above 100% funded. This is a critical ...

Please provide your email address to receive an email when new articles are posted on . Ten-year predicted ASCVD risk of 4% or more may serve as an adequate threshold for statin initiation based on ...

A panel of outside experts to the U.S. Food and Drug Administration voted ​against backing the risk-benefit profile of AstraZeneca's breast ‌cancer drug, the company said on Thursday.